Global Nuclear Medicine Diagnostic Equipment Industry Growth and Trends Forecast to 2031
Summary
According to APO Research, The global Nuclear Medicine Diagnostic Equipment market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Nuclear Medicine Diagnostic Equipment include GE HealthCare, Siemens Healthineers, CMR Naviscan, Compa?нa Mexicana, DDD-Diagnostic, Digirad, Mediso Medical Imaging Systems, Philips and Positron, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Diagnostic Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Diagnostic Equipment.
The Nuclear Medicine Diagnostic Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine Diagnostic Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Nuclear Medicine Diagnostic Equipment Segment by Company
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Diagnostic Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Diagnostic Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Diagnostic Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine Diagnostic Equipment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nuclear Medicine Diagnostic Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Nuclear Medicine Diagnostic Equipment market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Nuclear Medicine Diagnostic Equipment include GE HealthCare, Siemens Healthineers, CMR Naviscan, Compa?нa Mexicana, DDD-Diagnostic, Digirad, Mediso Medical Imaging Systems, Philips and Positron, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Diagnostic Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Diagnostic Equipment.
The Nuclear Medicine Diagnostic Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine Diagnostic Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Nuclear Medicine Diagnostic Equipment Segment by Company
- GE HealthCare
- Siemens Healthineers
- CMR Naviscan
- Compa?нa Mexicana
- DDD-Diagnostic
- Digirad
- Mediso Medical Imaging Systems
- Philips
- Positron
- SurgicEye
- TeraRecon
- Toshiba
- Top Grade Healthcare
- Neusoft Group
- United Imaging
- MinFound Medical
- SinoUnion Healthcare
- PET
- SPECT
- Tumor Imaging
- Endocrine System Imaging
- Urinary System Imaging
- Bone Marrow Imaging
- Others
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Poland
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America
- Brazil
- Argentina
- Chile
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Tьrkiye
- GCC Countries
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Diagnostic Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Diagnostic Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Diagnostic Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine Diagnostic Equipment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nuclear Medicine Diagnostic Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Nuclear Medicine Diagnostic Equipment Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Estimates and Forecasts (2020-2031)
1.3 Nuclear Medicine Diagnostic Equipment Market by Type
1.3.1 PET
1.3.2 SPECT
1.4 Global Nuclear Medicine Diagnostic Equipment Market Size by Type
1.4.1 Global Nuclear Medicine Diagnostic Equipment Market Size Overview by Type (2020-2031)
1.4.2 Global Nuclear Medicine Diagnostic Equipment Historic Market Size Review by Type (2020-2025)
1.4.3 Global Nuclear Medicine Diagnostic Equipment Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
1.5.2 Europe Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
1.5.4 South America Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
2 GLOBAL MARKET DYNAMICS
2.1 Nuclear Medicine Diagnostic Equipment Industry Trends
2.2 Nuclear Medicine Diagnostic Equipment Industry Drivers
2.3 Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges
2.4 Nuclear Medicine Diagnostic Equipment Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Nuclear Medicine Diagnostic Equipment Revenue (2020-2025)
3.2 Global Top Players by Nuclear Medicine Diagnostic Equipment Sales (2020-2025)
3.3 Global Top Players by Nuclear Medicine Diagnostic Equipment Price (2020-2025)
3.4 Global Nuclear Medicine Diagnostic Equipment Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Nuclear Medicine Diagnostic Equipment Major Company Production Sites & Headquarters
3.6 Global Nuclear Medicine Diagnostic Equipment Company, Product Type & Application
3.7 Global Nuclear Medicine Diagnostic Equipment Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Nuclear Medicine Diagnostic Equipment Market CR5 and HHI
3.8.2 Global Top 5 and 10 Nuclear Medicine Diagnostic Equipment Players Market Share by Revenue in 2024
3.8.3 2023 Nuclear Medicine Diagnostic Equipment Tier 1, Tier 2, and Tier
4 NUCLEAR MEDICINE DIAGNOSTIC EQUIPMENT REGIONAL STATUS AND OUTLOOK
4.1 Global Nuclear Medicine Diagnostic Equipment Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Nuclear Medicine Diagnostic Equipment Historic Market Size by Region
4.2.1 Global Nuclear Medicine Diagnostic Equipment Sales in Volume by Region (2020-2025)
4.2.2 Global Nuclear Medicine Diagnostic Equipment Sales in Value by Region (2020-2025)
4.2.3 Global Nuclear Medicine Diagnostic Equipment Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Nuclear Medicine Diagnostic Equipment Forecasted Market Size by Region
4.3.1 Global Nuclear Medicine Diagnostic Equipment Sales in Volume by Region (2026-2031)
4.3.2 Global Nuclear Medicine Diagnostic Equipment Sales in Value by Region (2026-2031)
4.3.3 Global Nuclear Medicine Diagnostic Equipment Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 NUCLEAR MEDICINE DIAGNOSTIC EQUIPMENT BY APPLICATION
5.1 Nuclear Medicine Diagnostic Equipment Market by Application
5.1.1 Tumor Imaging
5.1.2 Endocrine System Imaging
5.1.3 Urinary System Imaging
5.1.4 Bone Marrow Imaging
5.1.5 Others
5.2 Global Nuclear Medicine Diagnostic Equipment Market Size by Application
5.2.1 Global Nuclear Medicine Diagnostic Equipment Market Size Overview by Application (2020-2031)
5.2.2 Global Nuclear Medicine Diagnostic Equipment Historic Market Size Review by Application (2020-2025)
5.2.3 Global Nuclear Medicine Diagnostic Equipment Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
5.3.2 Europe Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
5.3.4 South America Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
6 COMPANY PROFILES
6.1 GE HealthCare
6.1.1 GE HealthCare Comapny Information
6.1.2 GE HealthCare Business Overview
6.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.1.5 GE HealthCare Recent Developments
6.2 Siemens Healthineers
6.2.1 Siemens Healthineers Comapny Information
6.2.2 Siemens Healthineers Business Overview
6.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio
6.2.5 Siemens Healthineers Recent Developments
6.3 CMR Naviscan
6.3.1 CMR Naviscan Comapny Information
6.3.2 CMR Naviscan Business Overview
6.3.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio
6.3.5 CMR Naviscan Recent Developments
6.4 Compa?нa Mexicana
6.4.1 Compa?нa Mexicana Comapny Information
6.4.2 Compa?нa Mexicana Business Overview
6.4.3 Compa?нa Mexicana Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Compa?нa Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio
6.4.5 Compa?нa Mexicana Recent Developments
6.5 DDD-Diagnostic
6.5.1 DDD-Diagnostic Comapny Information
6.5.2 DDD-Diagnostic Business Overview
6.5.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio
6.5.5 DDD-Diagnostic Recent Developments
6.6 Digirad
6.6.1 Digirad Comapny Information
6.6.2 Digirad Business Overview
6.6.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio
6.6.5 Digirad Recent Developments
6.7 Mediso Medical Imaging Systems
6.7.1 Mediso Medical Imaging Systems Comapny Information
6.7.2 Mediso Medical Imaging Systems Business Overview
6.7.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio
6.7.5 Mediso Medical Imaging Systems Recent Developments
6.8 Philips
6.8.1 Philips Comapny Information
6.8.2 Philips Business Overview
6.8.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Philips Nuclear Medicine Diagnostic Equipment Product Portfolio
6.8.5 Philips Recent Developments
6.9 Positron
6.9.1 Positron Comapny Information
6.9.2 Positron Business Overview
6.9.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Positron Nuclear Medicine Diagnostic Equipment Product Portfolio
6.9.5 Positron Recent Developments
6.10 SurgicEye
6.10.1 SurgicEye Comapny Information
6.10.2 SurgicEye Business Overview
6.10.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio
6.10.5 SurgicEye Recent Developments
6.11 TeraRecon
6.11.1 TeraRecon Comapny Information
6.11.2 TeraRecon Business Overview
6.11.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio
6.11.5 TeraRecon Recent Developments
6.12 Toshiba
6.12.1 Toshiba Comapny Information
6.12.2 Toshiba Business Overview
6.12.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio
6.12.5 Toshiba Recent Developments
6.13 Top Grade Healthcare
6.13.1 Top Grade Healthcare Comapny Information
6.13.2 Top Grade Healthcare Business Overview
6.13.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.13.5 Top Grade Healthcare Recent Developments
6.14 Neusoft Group
6.14.1 Neusoft Group Comapny Information
6.14.2 Neusoft Group Business Overview
6.14.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio
6.14.5 Neusoft Group Recent Developments
6.15 United Imaging
6.15.1 United Imaging Comapny Information
6.15.2 United Imaging Business Overview
6.15.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.15.4 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio
6.15.5 United Imaging Recent Developments
6.16 MinFound Medical
6.16.1 MinFound Medical Comapny Information
6.16.2 MinFound Medical Business Overview
6.16.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.16.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio
6.16.5 MinFound Medical Recent Developments
6.17 SinoUnion Healthcare
6.17.1 SinoUnion Healthcare Comapny Information
6.17.2 SinoUnion Healthcare Business Overview
6.17.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.17.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.17.5 SinoUnion Healthcare Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Nuclear Medicine Diagnostic Equipment Sales by Country
7.1.1 North America Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
7.1.3 North America Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
7.2 North America Nuclear Medicine Diagnostic Equipment Market Size by Country
7.2.1 North America Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
7.2.3 North America Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
8 EUROPE BY COUNTRY
8.1 Europe Nuclear Medicine Diagnostic Equipment Sales by Country
8.1.1 Europe Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
8.1.3 Europe Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
8.2 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country
8.2.1 Europe Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
8.2.3 Europe Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales by Country
9.1.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
9.1.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size by Country
9.2.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
10 SOUTH AMERICA BY COUNTRY
10.1 South America Nuclear Medicine Diagnostic Equipment Sales by Country
10.1.1 South America Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
10.1.3 South America Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
10.2 South America Nuclear Medicine Diagnostic Equipment Market Size by Country
10.2.1 South America Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
10.2.3 South America Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country
11.1.1 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
11.1.3 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size by Country
11.2.1 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Nuclear Medicine Diagnostic Equipment Value Chain Analysis
12.1.1 Nuclear Medicine Diagnostic Equipment Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Nuclear Medicine Diagnostic Equipment Production Mode & Process
12.2 Nuclear Medicine Diagnostic Equipment Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Nuclear Medicine Diagnostic Equipment Distributors
12.2.3 Nuclear Medicine Diagnostic Equipment Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Nuclear Medicine Diagnostic Equipment Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Estimates and Forecasts (2020-2031)
1.3 Nuclear Medicine Diagnostic Equipment Market by Type
1.3.1 PET
1.3.2 SPECT
1.4 Global Nuclear Medicine Diagnostic Equipment Market Size by Type
1.4.1 Global Nuclear Medicine Diagnostic Equipment Market Size Overview by Type (2020-2031)
1.4.2 Global Nuclear Medicine Diagnostic Equipment Historic Market Size Review by Type (2020-2025)
1.4.3 Global Nuclear Medicine Diagnostic Equipment Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
1.5.2 Europe Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
1.5.4 South America Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Breakdown by Type (2020-2025)
2 GLOBAL MARKET DYNAMICS
2.1 Nuclear Medicine Diagnostic Equipment Industry Trends
2.2 Nuclear Medicine Diagnostic Equipment Industry Drivers
2.3 Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges
2.4 Nuclear Medicine Diagnostic Equipment Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Nuclear Medicine Diagnostic Equipment Revenue (2020-2025)
3.2 Global Top Players by Nuclear Medicine Diagnostic Equipment Sales (2020-2025)
3.3 Global Top Players by Nuclear Medicine Diagnostic Equipment Price (2020-2025)
3.4 Global Nuclear Medicine Diagnostic Equipment Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Nuclear Medicine Diagnostic Equipment Major Company Production Sites & Headquarters
3.6 Global Nuclear Medicine Diagnostic Equipment Company, Product Type & Application
3.7 Global Nuclear Medicine Diagnostic Equipment Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Nuclear Medicine Diagnostic Equipment Market CR5 and HHI
3.8.2 Global Top 5 and 10 Nuclear Medicine Diagnostic Equipment Players Market Share by Revenue in 2024
3.8.3 2023 Nuclear Medicine Diagnostic Equipment Tier 1, Tier 2, and Tier
4 NUCLEAR MEDICINE DIAGNOSTIC EQUIPMENT REGIONAL STATUS AND OUTLOOK
4.1 Global Nuclear Medicine Diagnostic Equipment Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Nuclear Medicine Diagnostic Equipment Historic Market Size by Region
4.2.1 Global Nuclear Medicine Diagnostic Equipment Sales in Volume by Region (2020-2025)
4.2.2 Global Nuclear Medicine Diagnostic Equipment Sales in Value by Region (2020-2025)
4.2.3 Global Nuclear Medicine Diagnostic Equipment Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Nuclear Medicine Diagnostic Equipment Forecasted Market Size by Region
4.3.1 Global Nuclear Medicine Diagnostic Equipment Sales in Volume by Region (2026-2031)
4.3.2 Global Nuclear Medicine Diagnostic Equipment Sales in Value by Region (2026-2031)
4.3.3 Global Nuclear Medicine Diagnostic Equipment Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 NUCLEAR MEDICINE DIAGNOSTIC EQUIPMENT BY APPLICATION
5.1 Nuclear Medicine Diagnostic Equipment Market by Application
5.1.1 Tumor Imaging
5.1.2 Endocrine System Imaging
5.1.3 Urinary System Imaging
5.1.4 Bone Marrow Imaging
5.1.5 Others
5.2 Global Nuclear Medicine Diagnostic Equipment Market Size by Application
5.2.1 Global Nuclear Medicine Diagnostic Equipment Market Size Overview by Application (2020-2031)
5.2.2 Global Nuclear Medicine Diagnostic Equipment Historic Market Size Review by Application (2020-2025)
5.2.3 Global Nuclear Medicine Diagnostic Equipment Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
5.3.2 Europe Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
5.3.4 South America Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Breakdown by Application (2020-2025)
6 COMPANY PROFILES
6.1 GE HealthCare
6.1.1 GE HealthCare Comapny Information
6.1.2 GE HealthCare Business Overview
6.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.1.5 GE HealthCare Recent Developments
6.2 Siemens Healthineers
6.2.1 Siemens Healthineers Comapny Information
6.2.2 Siemens Healthineers Business Overview
6.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio
6.2.5 Siemens Healthineers Recent Developments
6.3 CMR Naviscan
6.3.1 CMR Naviscan Comapny Information
6.3.2 CMR Naviscan Business Overview
6.3.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio
6.3.5 CMR Naviscan Recent Developments
6.4 Compa?нa Mexicana
6.4.1 Compa?нa Mexicana Comapny Information
6.4.2 Compa?нa Mexicana Business Overview
6.4.3 Compa?нa Mexicana Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Compa?нa Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio
6.4.5 Compa?нa Mexicana Recent Developments
6.5 DDD-Diagnostic
6.5.1 DDD-Diagnostic Comapny Information
6.5.2 DDD-Diagnostic Business Overview
6.5.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio
6.5.5 DDD-Diagnostic Recent Developments
6.6 Digirad
6.6.1 Digirad Comapny Information
6.6.2 Digirad Business Overview
6.6.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio
6.6.5 Digirad Recent Developments
6.7 Mediso Medical Imaging Systems
6.7.1 Mediso Medical Imaging Systems Comapny Information
6.7.2 Mediso Medical Imaging Systems Business Overview
6.7.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio
6.7.5 Mediso Medical Imaging Systems Recent Developments
6.8 Philips
6.8.1 Philips Comapny Information
6.8.2 Philips Business Overview
6.8.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Philips Nuclear Medicine Diagnostic Equipment Product Portfolio
6.8.5 Philips Recent Developments
6.9 Positron
6.9.1 Positron Comapny Information
6.9.2 Positron Business Overview
6.9.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Positron Nuclear Medicine Diagnostic Equipment Product Portfolio
6.9.5 Positron Recent Developments
6.10 SurgicEye
6.10.1 SurgicEye Comapny Information
6.10.2 SurgicEye Business Overview
6.10.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio
6.10.5 SurgicEye Recent Developments
6.11 TeraRecon
6.11.1 TeraRecon Comapny Information
6.11.2 TeraRecon Business Overview
6.11.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio
6.11.5 TeraRecon Recent Developments
6.12 Toshiba
6.12.1 Toshiba Comapny Information
6.12.2 Toshiba Business Overview
6.12.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio
6.12.5 Toshiba Recent Developments
6.13 Top Grade Healthcare
6.13.1 Top Grade Healthcare Comapny Information
6.13.2 Top Grade Healthcare Business Overview
6.13.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.13.5 Top Grade Healthcare Recent Developments
6.14 Neusoft Group
6.14.1 Neusoft Group Comapny Information
6.14.2 Neusoft Group Business Overview
6.14.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio
6.14.5 Neusoft Group Recent Developments
6.15 United Imaging
6.15.1 United Imaging Comapny Information
6.15.2 United Imaging Business Overview
6.15.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.15.4 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio
6.15.5 United Imaging Recent Developments
6.16 MinFound Medical
6.16.1 MinFound Medical Comapny Information
6.16.2 MinFound Medical Business Overview
6.16.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.16.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio
6.16.5 MinFound Medical Recent Developments
6.17 SinoUnion Healthcare
6.17.1 SinoUnion Healthcare Comapny Information
6.17.2 SinoUnion Healthcare Business Overview
6.17.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2020-2025)
6.17.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.17.5 SinoUnion Healthcare Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Nuclear Medicine Diagnostic Equipment Sales by Country
7.1.1 North America Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
7.1.3 North America Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
7.2 North America Nuclear Medicine Diagnostic Equipment Market Size by Country
7.2.1 North America Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
7.2.3 North America Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
8 EUROPE BY COUNTRY
8.1 Europe Nuclear Medicine Diagnostic Equipment Sales by Country
8.1.1 Europe Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
8.1.3 Europe Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
8.2 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country
8.2.1 Europe Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
8.2.3 Europe Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales by Country
9.1.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
9.1.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size by Country
9.2.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
10 SOUTH AMERICA BY COUNTRY
10.1 South America Nuclear Medicine Diagnostic Equipment Sales by Country
10.1.1 South America Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
10.1.3 South America Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
10.2 South America Nuclear Medicine Diagnostic Equipment Market Size by Country
10.2.1 South America Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
10.2.3 South America Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country
11.1.1 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
11.1.3 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size by Country
11.2.1 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size Forecast by Country (2026-2031)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Nuclear Medicine Diagnostic Equipment Value Chain Analysis
12.1.1 Nuclear Medicine Diagnostic Equipment Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Nuclear Medicine Diagnostic Equipment Production Mode & Process
12.2 Nuclear Medicine Diagnostic Equipment Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Nuclear Medicine Diagnostic Equipment Distributors
12.2.3 Nuclear Medicine Diagnostic Equipment Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
